CRIS Current Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
EnglishFOLLO, MATILDE YUNG
Dipartimento:
DIPARTIMENTO DI SCIENZE BIOMEDICHE E NEUROMOTORIE
Ruolo:
Docenti di ruolo di IIa fascia
Risultati 1 - 20 di 97 (tempo di esecuzione: 0.0 secondi).
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | |
|---|---|---|---|---|---|---|
| 61 | The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resisten human T-acute leukemia cells by a JNK-dependent mechanism | Chiarini F.; Del Sole M.; Mongiorgi S.; Gaboardi G.C.; Cappellini A.; Mantovani I.; Follo M.Y.; McCubrey J.A.; Martelli A.M. | 2008 | LEUKEMIA | 1.01 Articolo in rivista | |
| 62 | The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation | Follo, Matilde Y.; Mongiorgi, Sara; Bosi, Costanza; Cappellini, Alessandra; Finelli, Carlo; Chiarini, Francesca; Papa, Veronica; Libra, Massimo; Martinelli, Giovanni; Cocco, Lucio; Martelli, Alberto M. | 2007 | CANCER RESEARCH | 1.01 Articolo in rivista | |
| 63 | The physiology and pathology of inositide signaling in the nucleus | Ramazzotti G.; Faenza I.; Fiume R.; Matteucci A.; Piazzi M.; Follo MY.; Cocco L. | 2011 | JOURNAL OF CELLULAR PHYSIOLOGY | 1.01 Articolo in rivista | |
| 64 | Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in cancer stem cells | Martelli AM; Evangelisti C; Follo MY; Ramazzotti G; Fini M; Giardino R; Manzoli L; McCubrey JA; Cocco L. | 2011 | CURRENT MEDICINAL CHEMISTRY | 1.01 Articolo in rivista | |
| 65 | Synergistic induction of PI-PLCbeta1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromes | Follo MY; Finelli C; Mongiorgi S; Clissa C; Chiarini F; Ramazzotti G; Paolini S; Martinelli G; Martelli AM; Cocco L | 2011 | LEUKEMIA | 1.01 Articolo in rivista | |
| 66 | Strategic Role of Nuclear Inositide Signalling in Myelodysplastic Syndromes Therapy | Manzoli L; Mongiorgi S; Clissa C; Finelli C; Billi AM; Poli A; Quaranta M; Cocco L; Follo MY | 2014 | MINI-REVIEWS IN MEDICINAL CHEMISTRY | 1.01 Articolo in rivista | |
| 67 | Specific presence of PKC isoforms in low and fast proliferation Moris hepatoma cells | P. Santi; L. Solimando; A.M. Billi; A. Cappellini; M.Y. Follo; N. Zini; L. Guidotti | 2004 | ITALIAN JOURNAL OF ANATOMY AND EMBRYOLOGY | 4.02 Riassunto (Abstract) | |
| 68 | SELECTIVE EFFECT OF LENALIDOMIDE ON CELL CYCLE AND INOSITIDE-DEPENDENT ERYTHROID SIGNALLING IN DEL(5Q) CELLS AND MYELODYSPLASTIC SYNDROMES (MDS) | Follo, My; Mongiorgi, S; Clissa, C; Poli, A; Lonetti, A; Stanzani, M; Cappellini, A; Billi, Am; Manzoli, L; Cocco, L; Finelli, C | 2014 | 4.02 Riassunto (Abstract) | ||
| 69 | Selective Activation of Nuclear PI-PLCbeta1 During Normal and Therapy-Related Differentiation | Mongiorgi, Sara; Follo, Matilde Y; Yang, Yong Ryoul; Ratti, Stefano; Manzoli, Lucia; Mccubrey, James A; Billi, Anna Maria; Suh, Pann-Ghill; Cocco, Lucio | 2016 | CURRENT PHARMACEUTICAL DESIGN | 1.01 Articolo in rivista | |
| 70 | ROLE OF INOSITIDE-DEPENDENT SIGNAL TRANSDUCTION PATHWAYS ON EPO-INDUCED EYTHROID DIFFERENTIATION IN LOW-RISK MDS PATIENTS | Follo MY; Mongiorgi S; Clissa C; Baccarani M; Paolini S; Curti A; Papayannidis C; Martinelli G; Manzoli L; Finelli C; Cocco L | 2012 | HAEMATOLOGICA | 4.01 Contributo in Atti di convegno | |
| 71 | Role of inositide signalling regulation in higher-risk MDS patients during epigenetic therapy | M.Y. Follo; S. Mongiorgi; C. Clissa; C. Bosi; M. Baccarani; G. Martinelli; L. Manzoli; C. Finelli; L. Cocco | 2011 | LEUKEMIA RESEARCH | 4.01 Contributo in Atti di convegno | |
| 72 | Revisiting nuclear phospholipase C signalling in MDS | Follo MY; Faenza I; Fiume R; Ramazzotti G; McCubrey JA; Martelli AM; Manzoli FA; Cocco L | 2012 | ADVANCES IN BIOLOGICAL REGULATION | 1.01 Articolo in rivista | |
| 73 | Reply to Herens et al. | Lo Vasco VR; Follo MY; Cocco L. | 2006 | LEUKEMIA | 1.04 Replica / breve intervento (e simili) | |
| 74 | Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS. | Follo MY; Finelli C; Mongiorgi S; Clissa C; Bosi C; Testoni N; Chiarini F; Ramazzotti G; Baccarani M; Martelli AM; Manzoli L; Martinelli G; Cocco L | 2009 | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | 1.01 Articolo in rivista | |
| 75 | Real-time PCR as a tool for quantitative analysis of PI-PLCbeta1 gene expression in myelodysplastic syndrome. | Follo MY; Bosi C; Finelli C; Fiume R; Faenza I; Ramazzotti G; Gaboardi GC; Manzoli L; Cocco L. | 2006 | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE | 1.01 Articolo in rivista | |
| 76 | Protein kinase C involvement in cell cycle modulation | Poli, Alessandro; Mongiorgi, Sara; Cocco, Lucio; Follo, Matilde Y. | 2014 | BIOCHEMICAL SOCIETY TRANSACTIONS | 1.01 Articolo in rivista | |
| 77 | PROSPECTIVE PHASE II STUDY ON LOW-DOSE 5-AZACYTIDINE FOR TREATMENT OF SYMPTOMATIC PATIENTS WITH LOW/INT-1 RISK MYELODISPLASIA | C Filì; M Follo; G Martinelli; I Iacobucci; F Cattina; C Skert; C Bergonzi; M Malagola; C Finelli; M Gobbi; A Candoni; F Lauria; F Lanza; A Turra; R Ribolla; V Cancelli; L Cocco; D Russo | 2012 | HAEMATOLOGICA | 4.02 Riassunto (Abstract) | |
| 78 | Prospective phase II Study on 5-days azacitidine for treatment of symptomatic and/or erythropoietin unresponsive patients with low/INT-1-risk myelodysplastic syndromes | Filì C; Malagola M; Follo MY; Finelli C; Iacobucci I; Martinelli G; Cattina F; Clissa C; Candoni A; Fanin R; Gobbi M; Bocchia M; Defina M; Spedini P; Skert C; Manzoli L; Cocco L; Russo D. | 2013 | CLINICAL CANCER RESEARCH | 1.01 Articolo in rivista | |
| 79 | Prolonged low-dose azacitidine schedule in high-risk MDS patients: Hematologic and molecular response | C. Finelli; C. Clissa; M. Follo; A. Curti; S. Paolini; C. Papayannidis; S. Mongiorgi; S. Parisi; L. Manzoli; G. Martinelli; L. Cocco; M. Baccarani | 2011 | LEUKEMIA RESEARCH | 4.02 Riassunto (Abstract) | |
| 80 | PROLONGED HEMATOLOGIC AND MOLECULAR RESPONSE AFTER A LIMITED NUMBER OF AZACITIDINE CYCLES IN LOW-RISK MYELODYSPLASTIC SYNDROMES | C Finelli;C Clissa; M Follo; D Russo; C Filì; A Curti;S Paolini; C Bosi; S Mongiorgi; L Manzoli; C Papayannidis; S Parisi; G Martinelli; L Cocco; M Baccarani | 2011 | HAEMATOLOGICA | 4.02 Riassunto (Abstract) |
Nome completo:
FOLLO, MATILDE YUNG
Varianti:
F. Matilde
FOLLO MY
MY Follo
Matilde Y. Follo
M. Follo
FOLLO MY
MY Follo
Matilde Y. Follo
M. Follo
Copyright © 2019